Drug Shortage Report for GABAPENTIN TABLETS USP

Last updated on 2018-12-11 History
Report ID 65691
Drug Identification Number 02392526
Brand name GABAPENTIN TABLETS USP
Common or Proper name GABAPENTIN
Company Name ACCORD HEALTHCARE INC
Market Status MARKETED
Active Ingredient(s) GABAPENTIN
Strength(s) 600MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 TABS/BOTTLE | 100 COMPRIMÉS/BOUTEILLE
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-10-29
Actual start date 2018-10-29
Estimated end date 2018-10-23
Actual end date 2018-11-30
Shortage status Resolved
Updated date 2018-12-11
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-10-29 English Compare
v2 2018-10-29 French Compare
v3 2018-10-30 English Compare
v4 2018-12-11 English Compare
v5 2018-12-11 French Compare

Showing 1 to 5 of 5